X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2215) 2215
Publication (225) 225
Book Chapter (15) 15
Magazine Article (7) 7
Book Review (6) 6
Web Resource (4) 4
Book / eBook (1) 1
Dissertation (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
zygomycosis (1646) 1646
humans (1433) 1433
mucormycosis (1004) 1004
index medicus (849) 849
male (845) 845
female (603) 603
antifungal agents - therapeutic use (542) 542
middle aged (506) 506
adult (479) 479
microbiology (415) 415
infectious diseases (403) 403
mycology (330) 330
mucormycosis - microbiology (300) 300
epidemiology (298) 298
mucormycosis - diagnosis (278) 278
amphotericin b - therapeutic use (277) 277
mucormycosis - drug therapy (272) 272
diagnosis (269) 269
aged (267) 267
infection (267) 267
zygomycosis - diagnosis (255) 255
zygomycosis - drug therapy (255) 255
infections (246) 246
immunocompromised host (243) 243
animals (241) 241
aspergillosis (238) 238
health aspects (226) 226
posaconazole (226) 226
amphotericin b (220) 220
fungi (219) 219
child (218) 218
risk factors (213) 213
immunology (212) 212
mycoses (212) 212
adolescent (206) 206
treatment outcome (201) 201
zygomycosis - microbiology (201) 201
amphotericin-b (193) 193
fatal outcome (192) 192
therapy (185) 185
transplantation (177) 177
voriconazole (177) 177
surgery (173) 173
fungal-infections (172) 172
mucormycosis - pathology (167) 167
fungal infections (165) 165
dermatology (163) 163
rhizopus (158) 158
veterinary sciences (157) 157
mortality (155) 155
zygomycosis - pathology (155) 155
patient (147) 147
care and treatment (146) 146
antifungal agents (144) 144
triazoles - therapeutic use (144) 144
mucormycosis - complications (140) 140
antifungal agents - administration & dosage (136) 136
disease (136) 136
young adult (134) 134
mucormycosis - etiology (125) 125
rhizopus - isolation & purification (125) 125
pathology (123) 123
mucorales - isolation & purification (120) 120
pharmacology & pharmacy (118) 118
rhinocerebral mucormycosis (118) 118
retrospective studies (117) 117
child, preschool (116) 116
diabetes (115) 115
pediatrics (114) 114
debridement (107) 107
diagnosis, differential (107) 107
mucormycosis - therapy (107) 107
mucorales (106) 106
leukemia (105) 105
management (104) 104
hematology (100) 100
amphotericin b - administration & dosage (98) 98
tomography, x-ray computed (94) 94
antifungal agents - pharmacology (93) 93
oncology (93) 93
zygomycosis - epidemiology (93) 93
zygomycosis - complications (89) 89
liposomal amphotericin-b (88) 88
medicine, general & internal (87) 87
salvage therapy (87) 87
diabetes mellitus (86) 86
invasive fungal-infections (86) 86
mucormycosis - epidemiology (86) 86
itraconazole (84) 84
mucormycosis - surgery (84) 84
identification (82) 82
infant (81) 81
pulmonary mucormycosis (81) 81
antiparasitic agents (78) 78
research (78) 78
biopsy (77) 77
zygomycosis - therapy (77) 77
aspergillus (75) 75
mycoses - drug therapy (75) 75
microbial sensitivity tests (74) 74
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1982) 1982
French (76) 76
Spanish (63) 63
German (42) 42
Portuguese (25) 25
Japanese (23) 23
Chinese (4) 4
Dutch (4) 4
Italian (4) 4
Turkish (4) 4
Polish (3) 3
Hungarian (2) 2
Danish (1) 1
Korean (1) 1
Russian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Emerging Infectious Diseases, ISSN 1080-6040, 09/2009, Volume 15, Issue 9, pp. 1395 - 1401
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 6/2012, Volume 54, Issue 12, pp. 1685 - 1691
Journal Article
Journal Article
Clinical Microbiology and Infection, ISSN 1198-743X, 12/2011, Volume 17, Issue 12, pp. 1859 - 1867
Zygomycosis is an important emerging fungal infection, associated with high morbidity and mortality. The Working Group on Zygomycosis of the European... 
treatment | zygomycosis | Epidemiology | mucormycosis | Europe | Mucormycosis | Treatment | Zygomycosis | VORICONAZOLE | INFECTIOUS DISEASES | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | AMPHOTERICIN-B | IN-VITRO SUSCEPTIBILITIES | CELL TRANSPLANT RECIPIENTS | POSACONAZOLE PROPHYLAXIS | SURVEILLANCE NETWORK TRANSNET | BREAKTHROUGH ZYGOMYCOSIS | HEMATOLOGIC MALIGNANCIES | Age Distribution | Diabetes Complications | Prospective Studies | Fungi - classification | Humans | Middle Aged | Zygomycosis - mortality | Child, Preschool | Fungi - isolation & purification | Infant | Male | Young Adult | Hematopoietic Stem Cell Transplantation - adverse effects | Aged, 80 and over | Adult | Female | Hematologic Neoplasms - complications | Child | Risk Factors | Wounds and Injuries - complications | Europe - epidemiology | Zygomycosis - epidemiology | Adolescent | Survival Analysis | Sex Distribution | Aged | Antifungal Agents - administration & dosage | Amphotericin B | Analysis | Antiparasitic agents | Transplantation | Diabetes | Health aspects | Hematopoietic stem cells | Multivariate analysis | Medical research | Mortality | Cell culture | Diabetes mellitus | stem cell transplantation | Case reports | Malignancy | Regression analysis | Survival | Trauma | Morbidity | Soft tissues | Infection | Databases | Surgery | Caspofungin | Posaconazole | Age
Journal Article